X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1592) 1592
Publication (58) 58
Book Review (41) 41
Magazine Article (8) 8
Dissertation (4) 4
Conference Proceeding (2) 2
Book Chapter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1077) 1077
tolterodine (929) 929
overactive bladder (696) 696
female (680) 680
male (675) 675
tolterodine tartrate (618) 618
urology & nephrology (618) 618
index medicus (608) 608
middle aged (525) 525
muscarinic antagonists - therapeutic use (494) 494
aged (486) 486
urinary bladder, overactive - drug therapy (435) 435
efficacy (423) 423
urinary incontinence (395) 395
treatment outcome (374) 374
oxybutynin (370) 370
benzhydryl compounds - therapeutic use (362) 362
adult (359) 359
cresols - therapeutic use (334) 334
pharmacology & pharmacy (255) 255
phenylpropanolamine - therapeutic use (249) 249
urinary incontinence - drug therapy (244) 244
quality-of-life (232) 232
muscarinic antagonists - adverse effects (227) 227
muscarinic antagonists - administration & dosage (224) 224
tolerability (217) 217
quality of life (211) 211
double-blind method (204) 204
aged, 80 and over (198) 198
benzhydryl compounds - administration & dosage (193) 193
incontinence (190) 190
safety (188) 188
urology (180) 180
double-blind (179) 179
urinary-incontinence (179) 179
benzhydryl compounds - adverse effects (174) 174
cresols - administration & dosage (174) 174
bladder (172) 172
phenylpropanolamine (171) 171
symptoms (167) 167
solifenacin (166) 166
women (160) 160
cresols - adverse effects (153) 153
medicine, general & internal (152) 152
urinary-tract symptoms (149) 149
drug therapy (146) 146
prospective studies (141) 141
animals (136) 136
mandelic acids - therapeutic use (135) 135
medicine & public health (135) 135
solifenacin succinate (135) 135
care and treatment (125) 125
tolterodine extended-release (125) 125
analysis (124) 124
detrusor overactivity (118) 118
cholinergic antagonists - therapeutic use (117) 117
muscarinic antagonists - pharmacology (117) 117
phenylpropanolamine - administration & dosage (117) 117
delayed-action preparations (115) 115
benign prostatic hyperplasia (113) 113
prevalence (110) 110
urge incontinence (108) 108
adolescent (106) 106
benzhydryl compounds - pharmacology (105) 105
dose-response relationship, drug (105) 105
urinary bladder, overactive - physiopathology (105) 105
drug therapy, combination (103) 103
urodynamics (98) 98
cresols - pharmacology (97) 97
obstetrics & gynecology (96) 96
fesoterodine (95) 95
randomized controlled trials as topic (95) 95
phenylpropanolamine - adverse effects (93) 93
pharmacokinetics (92) 92
men (91) 91
surveys and questionnaires (89) 89
urinary bladder - drug effects (89) 89
antimuscarinics (88) 88
trospium chloride (87) 87
mandelic acids - administration & dosage (86) 86
urinary bladder (86) 86
placebo (85) 85
antimuscarinic agent solifenacin (84) 84
extended-release (80) 80
young adult (80) 80
clinical trials (79) 79
severity of illness index (78) 78
antimuscarinic (75) 75
detrusor instability (75) 75
placebo-controlled trial (75) 75
darifenacin (74) 74
drugs (73) 73
mandelic acids - adverse effects (73) 73
quinuclidines - therapeutic use (73) 73
rats (73) 73
tetrahydroisoquinolines - therapeutic use (73) 73
tamsulosin (72) 72
therapy (72) 72
child (71) 71
extended-release tolterodine (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1497) 1497
German (41) 41
French (18) 18
Spanish (15) 15
Chinese (11) 11
Japanese (11) 11
Russian (9) 9
Swedish (3) 3
Turkish (3) 3
Italian (2) 2
Korean (2) 2
Polish (2) 2
Bulgarian (1) 1
Czech (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 296 - 305
Abstract Background Despite several antimuscarinic treatment options for overactive bladder (OAB), there is still a need for distinct treatment approaches to... 
Urology | Tolterodine | Overactive bladder | Mirabegron
Journal Article
Life Sciences, ISSN 0024-3205, 04/2001, Volume 68, Issue 22-23, pp. 2549 - 2556
Tolterodine is the first muscarinic receptor antagonist that has been specifically developed for the treatment of overactive bladder. The objectives in the... 
tolterodine
Journal Article
International journal of clinical pharmacology and therapeutics, ISSN 0946-1965, 2019, Volume 57, Issue 2, pp. 110 - 116
Journal Article
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2015, Volume 193, Issue 5, pp. 1572 - 1580
Purpose The purpose of this guideline amendment, herein referred to as the amendment, is to incorporate relevant newly published literature to better provide a... 
Urology | nocturia | urinary incontinence | urinary bladder | INCONTINENCE | TOXIN | DETRUSOR OVERACTIVITY | TOLTERODINE | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | TERMINOLOGY | Female | Male | Algorithms | Urinary Bladder, Overactive - diagnosis | Urinary Bladder, Overactive - therapy | Humans | Urinary incontinence | Care and treatment | Adults
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2016, Volume 129, Issue 24, pp. 2899 - 2906
Journal Article